Rocket Pharmaceuticals Inc

{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ 2.51, 23.12, 69.19, 169.6, 398.49 ], "ebit_estimate": [ -162.28, -206.64, -230.73, -166.34, 38.83 ], "ebitda_estimate": [ -56.25, -208.29, -216.44, null, null ], "net_income_estimate": [ -111.52, -179.48, -191.93, -160.09, 82.39 ], "per_share_eps_estimate": [ -0.93, -1.48, -1.34, -1.04, 0.56 ], "eps_nri_estimate": [ -1.01, -1.41, -1.15, -1, 0.38 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ 3.56, 2.25, 1.65, null, null ], "pretax_income_estimate": [ -96.26, -187.77, -203.95, -143.84, 94.59 ], "operating_cash_flow_per_share_estimate": [ 0.21, -1.16, -0.67, null, null ], "roa_estimate": [ -9.1, -37.4, -41.9, null, null ], "roe_estimate": [ -42.56, -52.84, -59.42, null, null ], "gross_margin_estimate": [ 75, 80, 80.5, 77, 78 ], "operating_cash_flow_estimate": [ 22.99, -129.52, -75.13, null, null ], "pettm_estimate": [ 0, 0, 0, 0, 7.01 ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": -16.34, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }

{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712" ], "revenue_estimate": [ 20, 0.77, 1.19, 3.12, 19.6, 24.9, 30.92 ], "ebit_estimate": [ 11.98, -48.48, -48.89, -50.12, -43.55, -41.69, -38.15 ], "ebitda_estimate": [ 136.27, -46.77, -50.57, -49.52, null, null, null ], "net_income_estimate": [ 59.88, -46.62, -46.02, -48.68, -42.42, -40.55, -36.94 ], "per_share_eps_estimate": [ 0.2, -0.43, -0.42, -0.43, -0.36, -0.34, -0.3 ], "eps_nri_estimate": [ 0.3, -0.43, -0.42, -0.42, -0.36, -0.34, -0.3 ], "dividend_estimate": [ null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null ], "pretax_income_estimate": [ 55.63, -47.01, -46.19, -48.68, -42.42, -40.55, -36.94 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null, null, null ], "gross_margin_estimate": [ null, 75, 75, 76, 74, 75, 76 ], "operating_cash_flow_estimate": [ null, null, null, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, null, null, null ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": -16.34, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }